Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma

Clinical Nuclear Medicine

Volumn 40, Issue 4, 2015, Pages 309-313

  Rowe, Steven P ^a   Gorin, Michael A ^a   Gordetsky, Jennifer ^a   Ball, Mark W ^a   Pierorazio, Phillip M ^a   Higuchi, Takahiro ^b   Epstein, Jonathan I ^a   Allaf, Mohamad E ^a   Javadi, Mehrbod S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

99mTc MIBI; Oncocytoma; Renal cell carcinoma; SPECT CT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; MIDDLE AGED; MITOCHONDRION; ONCOCYTOMA; QUALITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION STUDY; KIDNEY TUMOR; MULTIMODAL IMAGING; SCINTISCANNING;

ADENOMA, OXYPHILIC; ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925681582     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000670     Document Type: Article

References (18)

1. Gill IS, Aron M, Gervais DA, et al. Clinical practice. Small renal mass. N Engl J Med. 2010;362:624-634.
2. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331-1334.
3. Frank I, Blue ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217-2220.
4. Pierorazio PM, Hyams ES, Tsai S, et al. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncoctyoma. Urology. 2013;81:1265-1271.
5. Pedrosa I, Sun MR, Spencer M, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics. 2008;28: 985-1003.
6. JohnsonDC, Vukina J, SmithAB, et al. Preoperativelymisclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population-level burden estimate. J Urol. 2015;193:30-35.
7. Krishnan B, Truong LD. Renal epithelial neoplasm: the diagnostic implications of electron microscropic study of 55 cases. Hum Pathol. 2002;33:68-79.
8. Johnson NB, Johnson MM, Seliq MK, et al. Use of electron microscopy in core biopsy diagnosis of oncocytic renal tumors. Ultrastruct Pathol. 2010;34:189-194.
9. Gormley TS,Van Every MJ, Moreno AJ. Renal oncocytoma: preoperative diagnosis using technetium 99m sestamibi imaging. Urology. 1996;48:33-39.
10. Williams KA, Hill KA, Sheridan CM. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol. 2003;10:395-402.
11. 99mTc-MIBI uptake and P-glycoprotein expression in tumor tissue. Eur J Nucl Med. 1996;23: 976-979.
12. Chen CC, Meadows B, Regis J, et al. Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi. Clin Cancer Res . 1997;3: 545-552.
13. Bates SE, Bakke S, Kang M, et al. A phase I/II study of infusional vinblastinewith the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res. 2004;10:4724-4733.
14. Hurwitz GA, Ghali SK, Mattar AG, et al. Dynamic renal imaging with technetium-99m-sestamibi in hypertension: potential for assessment of renovascular disorders. J Nucl Med. 1994;35:1959-1964.
15. Simonnet H, Alazard N, Pfeiffer K, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogensis. 2002;23:759-768.
16. Rochlitz CF, Lobeck H, Peter S, et al. Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtype. Cancer. 1992;15:2993-2998.
17. Tobe SW, Noble-Topham SE, Andrulis IL, et al. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage. Clin Cancer Res. 1995;1:1611-1615.
18. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. Br J Cancer. 1998;77:353-358.